Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection
80 Participants (Two-thirds of Projected Recruitment) Enrolled IRVINE, Calif., July 29, 2024 (GLOBE NEWSWIRE) —...
Business
McDONALD’S REPORTS SECOND QUARTER 2024 RESULTS
Consolidated revenues for the quarter were nearly $6.5 billion, an increase over prior year of...
Acumen Pharmaceuticals Announces First Subject Dosed in Phase 1 Study of Subcutaneous Sabirnetug (ACU193) for Early Alzheimer’s Disease
NEWTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage...
Enstar Pref D stock hits 52-week low at $21.94 amid market shifts
In a challenging economic climate, Enstar Group Limited’s Preferred Shares Series D (ESGRP) touched a...
Surging yen upends popular global FX carry trades
By Alun John, Harry Robertson and Tom Westbrook LONDON/SINGAPORE (Reuters) – A perfect storm of...
Emerson’s Transformative GenAI Automation Delivers Powerful New Tool for Power and Water Industries
Ovation Automation Platform with GenAI will empower workforce, optimize operations PITTSBURGH, July 29, 2024 /PRNewswire/...
Heineken shares downgraded by CFRA amid earnings concerns
CFRA has downgraded shares of Heineken (AS:) (HEIA: NA) (OTC: HEINY (OTC:)) from Buy to...
GSK’s RSV vaccine gets positive opinion for broader age group
GSK plc (LSE/NYSE: GSK) announced today that the European Medicines Agency’s Committee for Medicinal Products...
Rapport Therapeutics to Present Data for TARPó8  AMPAR Negative Modulator  at IASP 2024 World Congress on Pain
Preclinical data on TARPγ8 targeted compound, an analog to Rapport’s lead product candidate RAP-219, demonstrated...
